Cytokinetics reported $81.7M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Acorda Therapeutics ACOR:US $ 39.24M 9.29M
Amgen AMGN:US $ 3.74B 804M
Arca Biopharma ABIO:US $ 5.68M 1.58M
Bayer BAYN:GR 10.43B 1.33B
Biogen BIIB:US $ 1921.1M 225.6M
Brainstorm Cell Therapeutics BCLI:US $ 5.48M 737K
Bristol Myers Squibb BMY:US $ 9.1B 247M
Capricor Therapeutics CAPR:US $ 7.83M 1.44M
Cytokinetics CYTK:US $ 81.7M 4.39M
Eisai 4523:JP Y 211704M 22380M
Eli Lilly And LLY:US $ 5405.7M 677M
Exelixis EXEL:US $ 272.74M 61.76M
Genocea Biosciences GNCA:US $ 16.04M 2.63M
Geron GERN:US $ 28.8M 3.22M
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
Intra Cellular Therapies ITCI:US $ 107.66M 4.02M
Ligand Pharmaceuticals LGND:US $ 53.5M 6.24M
Merk MRK:US $ 10332M 386M
Novartis NOVN:VX 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M